XPD DNA Nucleotide Excision Repair (NER) Gene Polymorphisms Associated with DNA Repair Deficiency May Predict Better Treatment Outcomes in Secondary Acute Myeloid Leukemia (AML).

Nataliya Kuptsova‐Clarkson, Kirsten Moysich(Roswell Park Comprehensive Cancer Center), Joli Weiss(Translational Genomics Research Institute), Maria R. Baer(University of Maryland, Baltimore), Gary Zirpoli(Roswell Park Comprehensive Cancer Center), Javier G. Blanco(Biomedical Research Institute), Kenneth J. Kopecky(City Of Hope National Medical Center), Laurie Ford(Roswell Park Comprehensive Cancer Center), Christine B. Ambrosone(Unknown), Lara Sucheston(Roswell Park Comprehensive Cancer Center), Meir Wetzler
Blood
November 20, 2009
10.1182/blood.v114.22.168.168
Cited by 25

Related Papers

Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
|Blood|1997|869
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862